Leading heart pump maker HeartWare International (HTWR) recently revealed that it has strengthened its HeartWare Ventricular Assist System portfolio in Europe with the CE Mark extension for long-term use in patients susceptible to fatal heart failure. The company has also published the U.S. clinical results of ADVANCE, an Investigational Device Exemption (“IDE”) study, designed to test the system as a bridge to heart transplantation for advanced heart failure patients.
The expanded CE … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards